- Home
- OSUR vs STRO Comparison
OSUR vs STRO Comparison
Compare OSUR & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- STRO
- Stock Information
- Founded
- OSUR 2000
- STRO 2003
- Country
- OSUR United States
- STRO United States
- Employees
- OSUR N/A
- STRO N/A
- Industry
- OSUR Medical/Dental Instruments
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSUR Health Care
- STRO Health Care
- Exchange
- OSUR Nasdaq
- STRO Nasdaq
- Market Cap
- OSUR 289.4M
- STRO 292.6M
- IPO Year
- OSUR 1986
- STRO 2018
- Fundamental
- Price
- OSUR $3.91
- STRO $2.84
- Analyst Decision
- OSUR Buy
- STRO Strong Buy
- Analyst Count
- OSUR 3
- STRO 7
- Target Price
- OSUR $6.67
- STRO $12.14
- AVG Volume (30 Days)
- OSUR 840.5K
- STRO 1.0M
- Earning Date
- OSUR 11-06-2024
- STRO 11-13-2024
- Dividend Yield
- OSUR N/A
- STRO N/A
- EPS Growth
- OSUR N/A
- STRO N/A
- EPS
- OSUR 0.15
- STRO N/A
- Revenue
- OSUR $224,263,000.00
- STRO $160,955,000.00
- Revenue This Year
- OSUR N/A
- STRO N/A
- Revenue Next Year
- OSUR N/A
- STRO N/A
- P/E Ratio
- OSUR $25.88
- STRO N/A
- Revenue Growth
- OSUR N/A
- STRO 230.90
- 52 Week Low
- OSUR $3.72
- STRO $2.45
- 52 Week High
- OSUR $8.45
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- OSUR 47.19
- STRO 41.69
- Support Level
- OSUR $3.75
- STRO $2.66
- Resistance Level
- OSUR $4.01
- STRO $2.86
- Average True Range (ATR)
- OSUR 0.14
- STRO 0.19
- MACD
- OSUR 0.01
- STRO 0.02
- Stochastic Oscillator
- OSUR 61.29
- STRO 78.00
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.